Disability News and Research

RSS

New 2026 guideline expands access to advanced acute ischemic stroke care

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke from the American Stroke Association, a division of the American Heart Association, published today in the Association's flagship journal Stroke.

26 Jan 2026

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in people with serious mental illnesses by targeting cardiometabolic risk rather than psychiatric symptoms alone. It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.

25 Jan 2026

Gaps in stroke transfer system reduces survivors' chances of receiving critical treatment

Gaps in the U.S. stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and increasing the likelihood that they will leave the hospital with a disability, according to a new study published in The Lancet Neurology.

21 Jan 2026

Stroke transfer delays reduce access to life-saving thrombectomy

Gaps in the nation's stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and increasing the likelihood that they will leave the hospital with a disability, a new study suggests.

21 Jan 2026

Pandemic linked to lasting drops in diagnosis rates for major conditions

There has been a lasting and disproportionate impact of the Covid-19 pandemic on diagnosis rates for conditions including depression, asthma and osteoporosis.

21 Jan 2026

Study finds late-career physician screening programs often lack fairness

Nearly 1 in 4 U.S. physicians with an active license is over age 65. This has spurred a small minority of hospitals to enact policies to assess these caregivers' cognitive and physical health, with the aim of reducing lapses that harm patients.

21 Jan 2026

Childhood ADHD traits linked to poorer physical health in midlife

People who have ADHD traits at age 10 are more likely than those without such traits to have physical health problems and to report physical health-related disability at age 46, according to a study led by University College London (UCL) and University of Liverpool researchers.

21 Jan 2026

Evidence shows no autism risk from paracetamol in pregnancy

Evidence from a comprehensive review shows no link between paracetamol in pregnancy and neurodevelopmental issues, supporting its safe use for pain management.

21 Jan 2026

Arthritis significantly restricts employment for millions of American adults

According to new research from the University of Delaware, nearly 40% of American adults ages 18 to 64 with arthritis - almost 10 million people - say the medical condition is limiting their ability to work.

21 Jan 2026

New AI learning tool bridges communication gaps between autistic and neurotypical people

People with autism have brains that are wired differently. This can make them especially strong in some areas-such as noticing patterns, remembering details, or thinking logically-while making other things like social cues or changes in routine more challenging.

20 Jan 2026

Early treatment delays rheumatoid arthritis onset in high-risk individuals

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with benefits also continuing well after treatment has stopped.

20 Jan 2026

Early pregnancy sulfur dioxide exposure raises odds of congenital limb defects

Maternal exposure to sulfur dioxide during the first trimester was associated with higher odds of congenital limb defects in offspring in a large population-based cohort from Wuhan. Associations were strongest for polydactyly and limb shortening, while other major air pollutants showed no consistent links with overall risk.

20 Jan 2026

HonorHealth patient first in Arizona to receive new investigational treatment for ischemic stroke

A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that targets platelets - rather than traditional clotting proteins - to help reopen blocked blood vessels in the brain.

20 Jan 2026

Understanding the trends of various neurological disorders in the Chinese population

Neurological disorders represent a mounting public health crisis in China, exacerbated by rapid population aging.

19 Jan 2026

Paracetamol use during pregnancy not linked to autism, ADHD or intellectual disability

Taking paracetamol during pregnancy does not increase the risk of autism, attention-deficit hyperactivity disorder (ADHD), or intellectual disability among children.

16 Jan 2026

Vagus nerve stimulation shows lasting benefit in treatment-resistant depression

Findings reveal that vagus nerve stimulation leads to lasting benefits in treatment-resistant depression, improving function and quality of life over two years.

16 Jan 2026

Cervical cancer association with unsafe sex and smoking

The study reveals deep inequalities in cervical cancer mortality linked to smoking and unsafe sex, highlighting the need for targeted prevention strategies.

15 Jan 2026

Phase II clinical trial shows promising results for novel sepsis drug

Griffith University researchers may have unlocked the secret to treating sepsis, with a Phase II clinical trial in China successfully concluding with promising results.

14 Jan 2026

Disease-responsive nanoparticles enable ghrelin mRNA therapy in osteoarthritis

Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior authors of a paper published in Nature Nanotechnology, "A disease-severity-responsive nanoparticle enables potent ghrelin mRNA therapy in osteoarthritis." Mahima Dewani, PhD, is the lead author of this study.

14 Jan 2026

Cannabidiol could become a therapeutic tool for fetal alcohol spectrum disorder

Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal alcohol spectrum disorder (FASD), a condition caused by alcohol exposure during pregnancy.

14 Jan 2026